agente e composição farmacêutica

Administration of the agent described herein significantly attenuates airway hyperresponsiveness, eosinophilia and lymphocytosis in the airways of sensitized animals. The effectiveness of the agent exceeds on all the evaluated parameters the commercial vaccine BCG Danish 1331 Strain.

Saved in:
Bibliographic Details
Main Authors BLANCA REYES MORENO, MARIA MERCÈ AMAT FABREGAT, ISABEL AMAT RIERA, PERE JOAN CARDONA IGLESIAS
Format Patent
LanguagePortuguese
Published 13.06.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Administration of the agent described herein significantly attenuates airway hyperresponsiveness, eosinophilia and lymphocytosis in the airways of sensitized animals. The effectiveness of the agent exceeds on all the evaluated parameters the commercial vaccine BCG Danish 1331 Strain.
Bibliography:Application Number: BR20141117217